WallStreetZenWallStreetZen

NASDAQ: MNPR
Monopar Therapeutics Stock Ownership - Who owns Monopar Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Monopar Therapeutics insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Kim R. TsuchimotoDirector2026-08-26615$109.56
$67.38kSell
Patrice RiouxInsider2026-08-261,380$0.01
$6.90Buy
Patrice RiouxInsider2026-08-261$111.26
$111.26Sell
Kim R. TsuchimotoDirector2026-08-26700$110.65
$77.46kSell
Kim R. TsuchimotoDirector2026-08-261,098$111.84
$122.80kSell
Kim R. TsuchimotoDirector2026-08-26602$112.93
$67.98kSell
Kim R. TsuchimotoDirector2026-08-26590$113.84
$67.17kSell
Kim R. TsuchimotoDirector2026-08-26485$108.83
$52.78kSell
Kim R. TsuchimotoDirector2026-08-26615$109.56
$67.38kSell
Kim R. TsuchimotoDirector2026-08-26700$110.65
$77.46kSell

1 of 5

MNPR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MNPR insiders and whales buy or sell their stock.

MNPR Shareholders

What type of owners hold Monopar Therapeutics stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Arthur J. Klausner136.69%9,174,944$942.27MInsider
Michael J. 1. Brown71.59%4,805,470$493.52MInsider
Tactic Pharma LLC65.30%4,383,299$450.16MInsider
Andrew Paul Mazar2.81%188,792$19.39MInsider
Chandler Robinson2.41%162,082$16.65MInsider
Christopher M. Starr1.70%113,853$11.69MInsider
Diane Hendricks1.40%93,750$9.63MInsider
Andrew Cittadine0.83%55,614$5.71MInsider
Lavina Talukdar0.21%14,001$1.44MInsider
Kim R. Tsuchimoto0.17%11,486$1.18MInsider

1 of 3

MNPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MNPR0.03%99.97%Net SellingNet Selling
OABI0.04%22.94%Net Selling
NGNE0.09%89.43%Net SellingNet Selling
ALT0.08%32.65%Net BuyingNet Buying
CBIO0.04%99.96%Net BuyingNet Buying
View Top Biotech Stocks

Monopar Therapeutics Stock Ownership FAQ

Who owns Monopar Therapeutics?

Monopar Therapeutics (NASDAQ: MNPR) is owned by 0.09% institutional shareholders, 283.33% Monopar Therapeutics insiders, and 0.00% retail investors. Arthur J. Klausner is the largest individual Monopar Therapeutics shareholder, owning 9.17M shares representing 136.69% of the company. Arthur J. Klausner's Monopar Therapeutics shares are currently valued at $885.11M.

If you're new to stock investing, here's how to buy Monopar Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.